E-cadherin expression in oesophageal carcinoma treated with high-dose radiotherapy; correlation with pretreatment parameters and treatment outcome

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 11, 1999, Pages 641-645

  Pomp, J ^a   Blom, J ^a   Van Krimpen, C ^a   Zwinderman, A H ^b   Immerzeel, J J F M ^a  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

E cadherin expression; Oesophageal carcinoma; Prognosis; Radiotherapy

Indexed keywords

UVOMORULIN;

ADENOCARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032712662     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050328     Document Type: Article

References (20)

1. Aberle H, Schwartz H, Kemler R (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J cell Biochem 61:514-523
2. Akimoto T, Mitshuhashi N, Saito Y, Ebara T, Niibe H (1998) Effect of radiation on the expression of E-cadherin and α-catenin and invasive capacity in human lung cancer cell line in vitro. Int J Radiat Oncol Biol Phys 41:1171-1176
3. Balsamo J, Leung T, Ernst H, Zanin MK, Hoffman S, Lilien J (1996) Regulated binding of PTPIB-Iike phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin. J Cell Biol 134:801-813
4. Bracke ME, Van Roy FM, Mareel MM (1996) The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 213:123-161
5. Bukholm IK, Nesland JM, Karesen R, Jacobsen U, Borresen Dale AL (1997) Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Virchows Arch 431:317-321
6. Cano A, Gamallo C, Kemp CJ, Benito N, Palacios J, Quintanilla M, Balmain A (1996) Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice. Int J Cancer 65:254-262
7. Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut M (1997) E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol 181:294-300
8. Dobson H, Pignatelli M, Hopwood D, D'Arrigo C (1994) Cell adhession molecules in oesophageal epithelium. Gut 35:1343-1347
9. Ebara T, Mitsuhashi N, Saito Y, Akimoto T, Niibe H (1998) Change in e-cadherin expression after x-ray irradiation of a human cancer cell line in vitro and in vivo. Int J Radiat Oncol Biol Phys 41:669-674
10. Essen CF von (1991) Radiation enhancement of metastasis: a review. Clin Exp Metastasis 9:77-104
11. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J cell Biol 113:173-185
12. Gunji N, Oda T, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A, Fukao K (1998) Pancreatic carcinoma - correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 82:1649-1656
13. Isaacs JT (1997) Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 150:1511-1521
14. Jian WG, Darnton SJ, Jenner K, Billingham LJ, Matthews HR (1997) Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance. J Clin Pathol 50:640-644
15. Krishnadath KK, Tilanus HW, Blankenstein M van, Hop WC, Kremers ED, Dinjens WN, Bosman FT (1997) Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182:331-338
16. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S (1997) Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 54:158-165
17. Pomp J, Davelaar J, Blom J, van Krimpen C, Zwinderman A, Quint W, Immerzeel J (1998) Radiotherapy for oesophagus carcinoma - the impact of p53 on treatment outcome. Radiother Oncol 46:179-184
18. Ruijter E, Vandekaa C, Aalders T, Ruiter D, Miller G, Debruyne F, Schalken J (1998) Heterogeneous expression of E-cadherin and p53 in prostate cancer - clinical implications. Mod Pathol 11:276-281
19. Tamura S, Shiozaki H, Miyata M, Kadowaki T, Inoue M, Matsui S, Iwazawa T, Takayama T, Takeichi M, Monden M (1996) Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br J Surg 83:1608-1614
20. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA (1994) Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929-3933.